Commercialization Services

Effectively progressing a product from concept through life-cycle management requires a small organization to develop and continually refine a clinical and economic product dossier.

We support our clients with Real-World Evidence (RWE) Data Solutions and Commercialization strategies. Facet helps small organizations generate evidence and build value from research and development to pre-launch to market positioning. In tandem, Facet works with your team to maximize post-product commercial launch positioning for patients, physicians, and payers.

Whether you plan to exit early or see your product all the way to commercialization, our approach facilitates maximum market value and positions you to achieve long term success.

Begin your Facet success story today!

Facet’s commercialization services include:

Market understanding:

Unmet medical need, including disease prognosis, disease progression, adverse events,
Natural history of disease
Current medical practice and treatment algorithms/guidelines
Market sizing – incidence, prevalence, duration of treatment, new treatment pathways, product adaption, payer adaption
Understanding patient populations – treatments received by patient type, outcomes by patient type or treatment
Competitive landscape analysis

Informing development:

Use of real-world data to inform trial design (i.e., patient inclusion/exclusion criteria, feasibility assessment, and clinical endpoints)
Clinical trial results inform product modeling, reimbursement strategy, and market position

Demonstrating asset value:

Informing post-product launch positioning for patients, physicians, and (efficacy, HRQoL, costs)
Competitor analysis – likely effectiveness targets required to displace established competitors, potential safety benefits, potential cost-savings, and patient benefits
Validation of:
- Efficacy – proving that real-world effectiveness matches efficacy shown in randomized clinical trials (RCTs)
- Safety – generating long-term safety data to provide reassurance to patients, prescribing physicians, health authorities, and payer coverage policy experts

Health Economics and Outcomes Research (HEOR):

Systematic literature reviews
Health economic gap analysis and mitigation of clinical and economic evidence gaps
Model structure identification (e.g., cost-effectiveness modeling, budget impact) and specification
Iterative validation of product patient, physician, and payer value at each stage of product development
Quality-of-life end points

Post-launch:

Validation of regulatory, clinical, medical, and economic assumptions to increase market and patient access, including:
- Market impact – impact of launched brand on standard of care, treatment algorithm, etc.
- Remaining unmet needs – prognosis, disease progression, adverse events
- Market sizing – market share, eligible market share based on label, off-label use

Lifecycle Management:

Line extension or new indications- real-world use analysis, pragmatic trials to support regulatory applications.

Begin your Facet success story today!

Summary of an Integrated Value Strategy Platform

Health Economics:

Early-stage economic modeling
Cost-effectiveness modeling
Burden of illness modeling
Epidemiology modeling
Cost-sharing modeling

U.S. / Global Value Dossier Development

Market understanding strategy development of dossier:

Commercial strategy
Assessment of payer perceptions and acceptance
Payer ad boards
Payer communication- understanding payer evidence needs

Pricing:

Qualitative and quantitative pricing research
Pricing strategy (e.g., evidence-based pricing strategy, value-based pricing strategy)
Value proposition development: Value to whom?
Messaging the true value of the product

Begin your Facet success story today!

Through to implementation of full service communications

Development

Stakeholder identification and educational needs mapping
Key external HCP expert identification and mapping
Competitor landscape mapping
Lexicon analysis
Scientific platform development
Communication strategy and plan development
Advisory boards
Clinical study recruitment / retention support
Investigator meetings
Publication planning and delivery

Pre-Launch

Activation of communication plan for all audiences
Internal company education and awareness (e-learning, news updates, etc)
HCP medical education materials
Scientific symposia
Advisory boards
Clinical study recruitment / retention support
Investigator meetings
Publication activities

Launch

Continue activation of communication plan as per
pre-launch
Affiliate medical meetings and best-practice sharing
Affiliate launch kit
HCP promotional materials
HCP medical education materials
Scientific symposia
Standalone meetings
Advisory boards
Clinical study recruitment / retention support
Investigator meetings
Publication activities
Phase IV clinical strategy development

Growth

Competitor landscape mapping
Continue communication activities as per pre-launch and launch for original indication and evidence grows
Product-specific RWE study activities
Revisit all ‘Development stage’ activities for new indications and / or formulations

Maturity

Continue communication activities for newer indications
Identify need for clinically sound post hoc analyses

Contact Facet today to establish and refine your product’s clinical and economic dossier to facilitate maximum market value and long-term market success!

Begin your Facet success story today!